CASI Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2022 to Q4 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
-
Summary
-
CASI Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2022 to Q4 2023.
- CASI Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending December 31, 2023 was $238K, a 543% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)